Point72 (Difc) LTD Veracyte, Inc. Transaction History
Point72 (Difc) LTD
- $2.72 Trillion
- Q4 2024
A detailed history of Point72 (Difc) LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 9,391 shares of VCYT stock, worth $300,699. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,391
Previous 12,788
26.56%
Holding current value
$300,699
Previous $435 Million
14.57%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$263 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$250 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$211 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$135 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$131 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.29B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...